Table 1. HHS and IOM quality of care indicators assessed using DC Cohort study dataa.
HHS Measure | HHS definition | IOM measure | IOM definition |
---|---|---|---|
Retention-in-care | Proportion of HIV+ persons who had ≥1 HIV medical care visit in each 6-month period of the 24 month measurement period, with ≥60 days between the first medical visit in the prior 6 month period and the last medical visit in the subsequent 6-month period among those with ≥24 months of follow-up | Proportion in continuous HIV care | Proportion of HIV+ people who had ≥2 routine HIV medical care visits or a CD4 or viral load test in the preceding 12 months ≥ 3 months apart among those with ≥12 months follow-up |
ARV therapy among persons in HIV medical care | Proportion of HIV+ persons who are prescribed ART in the 12-month measurement period among those with ≥12 months follow-up and ≥1 visit |
Regular CD4 testing for monitoring immune function |
Proportion of HIV+ people who received ≥2 CD4 tests in 12 months since enrollment among those with ≥12 months follow-up |
Viral load (VL) suppression among persons in care | Proportion of HIV+ persons with a viral load <200 copies/ml at last test in the 12–month measurement period among those with ≥12 months follow-up and ≥ 1 visit and ≥ 1 VL | Regular VL monitoring for clinical progression | Proportion of HIV+ people receiving ≥≥2 VL tests in 12 months since enrollment among those with ≥12 months follow-up |
Housing instability | Proportion of HIV+ persons who were homeless or unstably housed in the 12-month measurement period among those with ≥12 months follow-up with housing information recorded |
Maintenance of immune function to reduce risk of opportunistic infections and cancer |
Proportion of HIV+ people in continuous care for ≥12 months and with a CD4+ cell count ≥350 cells/mm3 among those in continuous care for ≥ 12 months |
Screening for Gonorrhea | Proportion of HIV+ people who were screened for Gonorrhea ≥1 since enrollment among those with ≥12 months follow-up | ||
Screening for Chlamydia | Proportion of HIV+ people who were screened Chlamydia ≥1 since enrollment among those with ≥12 months follow-up | ||
Screening for Syphilis | Proportion of HIV+ people who were screened for Syphilis ≥1 since enrollment among those with ≥12 months follow-up |
aIOM = Institute of Medicine; HHS = Department of Health and Human Services.